BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 24441131)

  • 1. Tuning solubility and stability of hydrochlorothiazide co-crystals.
    Sanphui P; Rajput L
    Acta Crystallogr B Struct Sci Cryst Eng Mater; 2014 Feb; 70(Pt 1):81-90. PubMed ID: 24441131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cocrystals of Hydrochlorothiazide: Solubility and Diffusion/Permeability Enhancements through Drug-Coformer Interactions.
    Sanphui P; Devi VK; Clara D; Malviya N; Ganguly S; Desiraju GR
    Mol Pharm; 2015 May; 12(5):1615-22. PubMed ID: 25800383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Designing of Stable Co-crystals of Zoledronic Acid Using Suitable Coformers.
    Varma A; Laxmi P; Pai A; Pai G; Sg V; Badamane Sathyanarayana M
    Chem Pharm Bull (Tokyo); 2019; 67(8):816-823. PubMed ID: 31366831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aerosil as a novel co-crystal co-former for improving the dissolution rate of hydrochlorothiazide.
    El-Gizawy SA; Osman MA; Arafa MF; El Maghraby GM
    Int J Pharm; 2015 Jan; 478(2):773-8. PubMed ID: 25529436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydrochloride salt co-crystals: preparation, characterization and physicochemical studies.
    Parmar VK; Shah SA
    Pharm Dev Technol; 2013; 18(2):443-53. PubMed ID: 22686294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solid-state form screen of cardiosulfa and its analogues.
    Kumar SS; Rana S; Nangia A
    Chem Asian J; 2013 Jul; 8(7):1551-68. PubMed ID: 23616361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase transformation in conformational polymorphs of nimesulide.
    Sanphui P; Sarma B; Nangia A
    J Pharm Sci; 2011 Jun; 100(6):2287-99. PubMed ID: 21491446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simvastatin-Nicotinamide Co-Crystals: Formation, Pharmaceutical Characterization and in vivo Profile.
    Khan FM; Ahmad M; Idrees HA
    Drug Des Devel Ther; 2020; 14():4303-4313. PubMed ID: 33116417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New conformational polymorph of hydrochlorothiazide with improved solubility.
    Saini A; Chadha R; Gupta A; Singh P; Bhandari S; Khullar S; Mandal S; Jain DS
    Pharm Dev Technol; 2016 Aug; 21(5):611-8. PubMed ID: 25975587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of analytical tools and multivariate methods for quantification of co-former crystals in ibuprofen-nicotinamide co-crystals.
    Soares FL; Carneiro RL
    J Pharm Biomed Anal; 2014 Feb; 89():166-75. PubMed ID: 24291798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sucralose as co-crystal co-former for hydrochlorothiazide: development of oral disintegrating tablets.
    Arafa MF; El-Gizawy SA; Osman MA; El Maghraby GM
    Drug Dev Ind Pharm; 2016 Aug; 42(8):1225-33. PubMed ID: 26555927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural Characterization of Co-Crystals of Chlordiazepoxide with
    Garbacz P; Paukszta D; Sikorski A; Wesolowski M
    Pharmaceutics; 2020 Jul; 12(7):. PubMed ID: 32659986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, characterization, and molecular modeling of a pharmaceutical co-crystal: (2-chloro-4-nitrobenzoic acid):(nicotinamide).
    Lemmerer A; Esterhuysen C; Bernstein J
    J Pharm Sci; 2010 Sep; 99(9):4054-71. PubMed ID: 20574994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel furosemide cocrystals and selection of high solubility drug forms.
    Goud NR; Gangavaram S; Suresh K; Pal S; Manjunatha SG; Nambiar S; Nangia A
    J Pharm Sci; 2012 Feb; 101(2):664-80. PubMed ID: 22081478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binary co-crystals of the active pharmaceutical ingredient 1,4-bis(4-pyridyl)-2,3-diaza-1,3-butadiene and camphoric acid.
    Bisht KK; Patel P; Rachuri Y; Eringathodi S
    Acta Crystallogr B Struct Sci Cryst Eng Mater; 2014 Feb; 70(Pt 1):63-71. PubMed ID: 24441129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stable Co-crystals of Glipizide with Enhanced Dissolution Profiles: Preparation and Characterization.
    Pandey NK; Sehal HR; Garg V; Gaur T; Kumar B; Singh SK; Gulati M; Gowthamarajan K; Bawa P; Rajesh SY; Sharma P; Narang R
    AAPS PharmSciTech; 2017 Oct; 18(7):2454-2465. PubMed ID: 28176212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization and evaluation of multi-component crystals of hydrochlorothiazide.
    Chadha R; Bhandari S; Khullar S; Mandal SK; Jain DV
    Pharm Res; 2014 Sep; 31(9):2479-89. PubMed ID: 24752477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Egg White Protein Carrier-Assisted Development of Solid Dispersion for Improved Aqueous Solubility and Permeability of Poorly Water Soluble Hydrochlorothiazide.
    Telange DR; Jain SP; Pethe AM; Kharkar PS
    AAPS PharmSciTech; 2021 Mar; 22(3):94. PubMed ID: 33683493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and formulation of progesterone para-aminobenzoic acid co-crystals with improved dissolution and stability.
    Hibbard T; Shankland K; Al-Obaidi H
    Eur J Pharm Biopharm; 2024 Mar; 196():114202. PubMed ID: 38309539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitrofurantoin-p-aminobenzoic acid cocrystal: hydration stability and dissolution rate studies.
    Cherukuvada S; Babu NJ; Nangia A
    J Pharm Sci; 2011 Aug; 100(8):3233-3244. PubMed ID: 21425165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.